Global Market Reach Molbio Diagnostics has established a strong presence in over 85 countries, indicating significant international demand for its portable and scalable diagnostic solutions. This offers opportunities to expand sales efforts in emerging markets and regions with high infectious disease burdens.

Innovative Product Portfolio The company's flagship Truenat platform and recent launches like Truenat HPV-HR Plus demonstrate a continuous pipeline of advanced, WHO-endorsed diagnostics that can be marketed to healthcare providers, labs, and government health agencies investing in point-of-care and screening technologies.

Recent Funding & Expansion With significant funding of $85 million and plans to go public, Molbio is positioned to scale operations, increase R&D, and expand sales channels, especially toward hospitals, clinics, and public health sectors seeking innovative diagnostic tools.

Recognition & Industry Awards Winning awards such as the Kochon Prize enhances brand credibility and opens doors with global health organizations, governments, and NGOs, providing a strategic advantage in bidding for large public health projects and partnerships.

Strategic Collaborations Partnerships like the one with UE LifeSciences for expanding breast cancer screening showcase opportunities to cross-sell diagnostic solutions across diverse medical fields and increase penetration in specialized healthcare segments.